Specific binding of the 1251-labeled human S protein (vitronectin) which has been shown to be identical with serum-spreading factor, was observed with group A, C, and G streptococci as well as with Staphylococcus aureus and Escherichia coli. The specific binding of S protein to group A, C, and G streptococci was high, whereas the binding to S. aureus Human S protein exists in its native form as a 4.6S single-chain polypeptide with a molecular weight of about 78,000 and in a proteolyzed form with a molecular weight of about 65,000 (10, 33, 38) . The normal concentration of S protein in plasma is between 4 and 6 ,uM (38). S protein was initially described as an inhibitor of complement-mediated cell lysis (19). As such it blocks bystander cell lysis and membrane insertion of precursor complexes of the membrane attack complex (30-32). Thus the final assembly of the membrane attack complex, which is based on the polymerization of the terminal complement component C9 (49), is blocked by S protein (34), resulting in macromolecular structures lacking the tubular morphology of poly C-9 (37). S protein is also able to bind to enzyme-inhibitor complexes in the terminal stage of the coagulation pathway (17, 29, 39). In addition, it interferes with the thrombin-antithrombin III reaction by counteracting the accelerative effect of heparin in this inhibition, thereby protecting thrombin against fast inactivation (29, 36) .
Human S protein exists in its native form as a 4.6S single-chain polypeptide with a molecular weight of about 78,000 and in a proteolyzed form with a molecular weight of about 65,000 (10, 33, 38) . The normal concentration of S protein in plasma is between 4 and 6 ,uM (38) . S protein was initially described as an inhibitor of complement-mediated cell lysis (19) . As such it blocks bystander cell lysis and membrane insertion of precursor complexes of the membrane attack complex (30) (31) (32) . Thus the final assembly of the membrane attack complex, which is based on the polymerization of the terminal complement component C9 (49) , is blocked by S protein (34) , resulting in macromolecular structures lacking the tubular morphology of poly C-9 (37). S protein is also able to bind to enzyme-inhibitor complexes in the terminal stage of the coagulation pathway (17, 29, 39) . In addition, it interferes with the thrombin-antithrombin III reaction by counteracting the accelerative effect of heparin in this inhibition, thereby protecting thrombin against fast inactivation (29, 36) .
Besides its role in complement-dependent cell lysis and the coagulation system, S protein has been recognized as a promoter of cellular adhesion and spreading of cells (2, 14) . It shows a high degree of similarity with respect to structural and functional properties with the serum-spreading factor vitronectin (35, 47) , and the amino acid sequences of both proteins share more than 98% homology (18, 45) . The effects of S protein (vitronectin) on cell adhesion are similar to those of fibronectin (16, 40, 41) , another adhesive protein present in plasma. The two proteins are, however, different by biochemical, immunological, and structural criteria (2, 13, 44) . Fibronectin has specific binding sites on staphylococci and streptococci (23, 28, 46) and serves as receptor in the adherence of bacteria to host cells (1, 8, 42, 49, 50 Purification of S protein. S protein was purified from platelet-poor human plasma as previously described (38) . Briefly, the method consisted of barium citrate adsorption, ammonium sulfate precipitation, chromatography on DEAESephacel and Blue Sepharose, and gel filtration on Sephacryl S-300 (Pharmacia, Uppsala Sweden). The yield was approximately 5%, and the purified protein was homogeneous as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (24) and Western blot analysis (48) . Antibodies against human S protein were raised in rabbits, and the immunoglobulin G fraction was prepared by standard methods. The rabbit immunoglobulin G fraction against human fibronectin was obtained from Dakopatts, Hamburg, Federal Republic of Germany.
Radioiodination. S protein was radiolabeled with 1251 (carrier free) (New England Nuclear Corp., Dreieich, Federal Republic of Germany) by using the chloramine T method (15) . Of the added radioactivity, 78% was incorporated into S protein as determined after precipitation with trichloroacetic acid; the specific activity was 1.4 mCi/mg. Radiolabeled S protein was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (24) , and the distribution of radiolabel was detected by autoradiography.
Binding assay. The method of Kronvall et al. (21) for the binding assay was used essentially as previously described (9) . The bacteria were washed twice in 0.15 M phosphatebuffered saline (pH 7.5) (PBS) and suspended in PBS containing 0.05% Tween 20 (PBS-Tween). The test suspension was adjusted photometrically at 620 nm (Spectronic 20; Bausch and Lomb, Inc. Rochester, N.Y.) to contain approximately 109 bacteria per ml. A 20-,ul sample of labeled S protein (2 ,ug/ml) was added to 0.2 ml of the bacterial suspension, and after incubation for 1 h at room temperature, the bacteria were centrifuged at 10,000 x g and washed with ice-cold PBS-Tween. The radioactivity in the sediment was measured in a -y-spectrometer (Packard Instrument Co., Inc., Rockville, Md.). The uptake of radioactivity was expressed as the percentage of the total activity remaining in the pellet. In inhibition experiments, labeled S protein was preincubated with unlabeled S protein, fibronectin (purified by the method of Miekka et al. [25] (Fig. 1) . S protein showed the characteristic doublet when analyzed by immunoblotting with anti-S protein antibodies but did not cross-react with antibodies against fibronectin. The functional properties of S protein were demonstrated by its ability to inhibit complement-dependent lysis, to neutralize the anticoagulant activity of heparin in the thrombin-antithrombin III reaction (38) , and to promote attachment of fibroblasts (35 higher trypsin concentrations (Fig. 2) . Similar differences were observed with heat-treated bacteria. Heating the bacteria at 80°C for 40 min led to about a 75% loss in the binding of S protein to group G streptococci, S. aureus, and E. coli cultures. The group A and C streptococcal cultures, however, did not lose their S-protein binding capacity even after prolonged heating at 80°C (Fig. 3) .
Specificity of binding. Inhibition experiments were conducted to evaluate the specificity of S-protein binding to bacterial cultures. In all cultures to which 100 ng of 1251_ labeled S protein was added, the binding of radiolabeled S protein was almost completely inhibited by 2 ,ug of unlabeled S protein, wheras 50 ,g of unlabeled albumin was ineffective in displacing labeled S protein (Fig. 4) . Likewise, at the same concentration as albumin, other plasma proteins such as immunoglobulin G, a2-macroglobulin, haptoglobulin, 12-microglobulin, or transferrin did not significantly inhibit S-protein binding.
Binding of labeled S protein in the presence of unlabeled fibronectin and heparin further revealed the existence of two different bacterial binding sites for S protein. Fibronectin, as well as heparin, inhibited the binding of labeled S protein in group G streptococci and E. coli cultures but not in group A and C streptococci (Fig. 4) cultures indicated competitive inhibition by fibronectin, whereas the inhibition due to heparin was noncompetitive (Fig. 5) . The binding of S protein to group G streptococci was also partially inhibited by synthetic peptide Gly-ArgGly-Asp-Ser. This peptide had no influence on the binding of S protein to group A streptococci (Fig. 6) . Binding of proteolyzed S protein. Since S protein could also exist in a proteolyzed form in vivo, we determined the binding of trypsinized '25I-labeled S protein to selected strains of different bacterial species. For group A and C streptococcal cultures, the binding of trypsinized S protein was considerably less than that of untreated S protein. For group G streptococci, S. aureus, and E. coli cultures, however, no such difference was observed (Fig. 7) . DISCUSSION Several interactions of host plasma proteins with certain pathogenic bacteria have been described previously (3, 5, 8, 20, 22, 27) . There is evidence that the binding of host proteins to bacteria plays a role in the pathogenicity of the bacteria (3, 51) . Fibrinogen binding to streptococci, for example, inhibits the fixation of the third component of human complement (4, 6) , the fibronectin has been identified as a mediator for streptococcal adherence to epithelial cells and thus plays a role in the initiation of infection (43) . Since S protein plays an important role as an inhibitor of complement-mediated cells lysis (19, 31, 34) , as a regulator in the terminal phase of the coagulation system (17, 29, 38, 39) , and as a promoter of cellular adhesion (13, 35, 45) , its interaction with bacteria might influence the process of infection as well.
The interaction of S protein with bacteria was more pronounced with gram-positive cocci, as was described for other plasma proteins (4, 8) . In addition, prominent binding of S protein to S. aureus, which has been reported recently (12) (44) . Support for this interpretation stems from the fact that fibronectin appeared to competitively inhibit S-protein binding and that fibronectin has also been shown to bind to S. aureus (26) and E. coli (11) 
